- Zacks•18 hours ago
Acquisitions are back in focus in the biotech sector with Medivation (MDVN) agreeing to be acquired by Pfizer for $14 billion.
- TheStreet.com•21 hours ago
Leerink trimmed its price target on Gilead Sciences (GILD) stock today as it anticipates lower revenue from HIV sales in the future.
Gilead Sciences Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||80.40 x 1000|
|Ask||80.68 x 200|
|Day's Range||80.18 - 82.10|
|52wk Range||77.92 - 113.31|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||7.07|
|Avg Vol (3m)||10,121,612|
|Dividend & Yield||1.88 (2.31%)|